Postmarketing surveillance for drug safety.
Holden
William L
WL
Scarazzini
Linda J
LJ
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects; D000077339:Leflunomide; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D011358:Product Surveillance, Postmarketing / Q000592:standards*; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007555:Isoxazoles; D000077339:Leflunomide